Philippe Halfon mostly deals with Internal medicine, Gastroenterology, Fibrosis, Hepatitis C virus and FibroTest. His study looks at the relationship between Internal medicine and fields such as Viral load, as well as how they intersect with chemical problems. His research integrates issues of Biopsy, Liver biopsy and Predictive value of tests in his study of Gastroenterology.
His research on Hepatitis C virus is centered around Virology and Immunology. The study incorporates disciplines such as Protease inhibitor and Reverse transcriptase in addition to Virology. Within one scientific family, Philippe Halfon focuses on topics pertaining to Alcoholic liver disease under FibroTest, and may sometimes address concerns connected to Chronic liver disease and Biomarker.
His primary areas of investigation include Virology, Internal medicine, Hepatitis C virus, Immunology and Gastroenterology. His Virology research includes elements of RNA and Genotype. His work deals with themes such as Chronic hepatitis and Oncology, which intersect with Internal medicine.
He has included themes like Hepatitis C and Alpha interferon in his Hepatitis C virus study. His biological study spans a wide range of topics, including Liver disease and Liver function tests. His research in Virus intersects with topics in Reverse transcriptase and Hepatitis.
His main research concerns Internal medicine, Virology, Viral load, Immunology and Cancer research. His Internal medicine research includes themes of Gastroenterology and Oncology. He combines subjects such as Ribavirin and Boceprevir with his study of Gastroenterology.
His Virology study combines topics in areas such as Dolutegravir, Hiv infected patients and DNA sequencing. His studies in Viral load integrate themes in fields like Reverse transcription polymerase chain reaction, Hepatitis C virus, Cervical cancer, Real-time polymerase chain reaction and Hepatitis B virus. His Hepatitis C virus study frequently links to related topics such as Cirrhosis.
Philippe Halfon focuses on Internal medicine, Immunology, Hepatitis C, Hepatitis C virus and NS5A. Philippe Halfon interconnects Surgery and Viral load in the investigation of issues within Internal medicine. As a part of the same scientific study, he usually deals with the Hepatitis C, concentrating on Ribavirin and frequently concerns with Gastroenterology.
His Hepatitis C virus research is multidisciplinary, relying on both Interleukin and Cirrhosis. His studies deal with areas such as Regimen and Drug resistance as well as NS5A. The Ledipasvir study which covers Fixed-dose combination that intersects with Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial
J. Durant;P. Clevenbergh;P. Halfon;P. Delgiudice.
The Lancet (1999)
Meta-analyses of FibroTest diagnostic value in chronic liver disease
Thierry Poynard;Rachel Morra;Philippe Halfon;Laurent Castera.
BMC Gastroenterology (2007)
Hepatitis C virus resistance to protease inhibitors.
Philippe Halfon;Stephen Locarnini.
Journal of Hepatology (2011)
CpG methylation controls reactivation of HIV from latency.
Jana Blazkova;Katerina Trejbalova;Katerina Trejbalova;Françoise Gondois-Rey;Philippe Halfon.
PLOS Pathogens (2009)
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
Vivien Béziat;Vivien Béziat;Vivien Béziat;Olav Dalgard;Tarik Asselah;Philippe Halfon.
European Journal of Immunology (2012)
HCV direct‐acting antiviral agents: the best interferon‐free combinations
Raymond Schinazi;Philippe Halfon;Patrick Marcellin;Tarik Asselah.
Liver International (2014)
Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.
J Durant;P Clevenbergh;R Garraffo;P Halfon.
Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages
Thierry Poynard;Philippe Halfon;Laurent Castera;Mona Munteanu.
Clinical Chemistry (2007)
SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C
Giada Sebastiani;Philippe Halfon;Laurent Castera;Stanislas Pol.
Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study
Philippe Halfon;Marc Bourliere;Romaric Deydier;Danielle Botta-Fridlund.
The American Journal of Gastroenterology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: